Preparedness cannot be built during an emergency. In a new @statnews op-ed, W. Craig Vanderwagen and Jennifer B. Alton - architects of the original Pandemic and All-Hazards Preparedness Act - make the case for why Congress must reauthorize PAHPA now and confirm leadership at both ASPR and the CDC. Read more: statnews.com/2026/06/16/aspr…

A new analysis from @MagnoliaAccess warns the U.S. biopharmaceutical ecosystem is at risk, with projections showing up to a 55% decline in drugs reaching the market over the next 20 years. See how changes in research funding, regulatory uncertainty, and drug pricing policies could affect the future of drug development. Read the report: “The U.S. Biopharmaceutical Innovation Ecosystem at Risk: The 20-Year Threat to U.S. Innovation and Cures.” magnoliamarketaccess.com/ins…

Ahead of #BIO2026, we asked Chris Rofidal, Senior Director of Health Policy and Pipeline Strategy at @UTHRMed, what he's driven by: "I'm driven by innovation... we have to have innovative products to get to our patients to change lives, to save lives." Learn more: convention.bio.org

AI is transforming biotech - and the #BIO2026 AI Summit on Monday, June 22 is where industry tech experts will share real-world, concrete examples of how AI is being meaningfully implemented to accelerate drug discovery, improve R&D productivity, and enable new scientific approaches. Learn more: convention.bio.org

Come to #BIO2026 with more than a badge - come with a calendar full of productive 1:1 meetings. BIO Partnering™ connects you to the people who can move your work forward. Start scheduling: convention.bio.org

Michael Stocum, President and CEO of @bantampharma, is coming back to #BIO2026 to build on the relationships and progress made last year after participating in BIO Partnering™ - and to share what it means for the cancer patients his work will serve. Learn more and register: convention.bio.org

At BIO 2026, biotech innovators, partners, and advocates from around the globe will come together — united by an unwavering conviction to solve the impossible, push boundaries, and make lives better — because together, our industry and our mission are driven by purpose. #BIO2026 Register: convention.bio.org

Tomorrow, June 11: BIO Senior Director of Patient Advocacy Karin Hoelzer is moderating a panel at the @OrphanConf in Boston on how industry, CMS, and patients can advance access to orphan drugs. The discussion will cover coverage pathways, evidence generation, and collaborative approaches to expanding access for rare disease patients. Learn more: terrapinn.com/conference/wor… #RareDisease #Biotech

As the June 12 onshoring plan deadline nears, uncertainty around Section 232 pharmaceutical tariffs continues to pose real challenges for biotech innovators. What do companies still need to know - and how could this shape the future of the industry? Read the latest from Bio.News: bio.news/latest-news/section… #Biotech #BioInnovation

Tomorrow at 12 PM ET, join BIO and the @NatPress for a free webinar on vaccine policy for health journalists. Claim your seat: nationalpress.org/training/r… #Vaccines #BiotechInnovation

Hear from Audrey Greenberg, @MayoClinic Venture Partner & Chair of the Department of Business Development, on what BIO Partnering™ has meant to her work and the broader ecosystem – from therapeutics and diagnostics to enabling platforms and digital health. #BIO2026 is just around the corner. Learn more and register: convention.bio.org

The #BIO2026 Exhibit Hall is your chance to discover leading biotech companies and the latest innovations across the industry. Browse the Exhibitor Directory and plan your visit today. Convention.bio.org

In a June 4 House hearing on medicines and patent policy, lawmakers weighed in on the role of IP protections in driving biotech innovation. Read the latest on Bio.News: bio.news/federal-policy/lawm… #IP #Biotech

At #BIO2026, we’re bringing lessons in leadership from the field to the main stage. Join @Marcus_Freeman1, Head Football Coach at the University of @NotreDame, as he kicks off Tuesday’s program with an inspiring fireside chat moderated by BIO President & CEO John F. Crowley. Widely respected for his intentional leadership style - blending determination, resolve, and an unmistakable competitive edge - Coach Freeman will draw on powerful lessons in leadership and resilience, exploring what it truly means to be “Driven by Purpose.” Learn more: convention.bio.org

Today, BIO President and CEO John F. Crowley joined @SCClemons at the Bold Bets Healthcare Summit to discuss how the U.S. can lead the world in healthcare innovation. Crowley underscored the importance of a healthy biotech ecosystem and greater access to medicines, as well as the role that storytelling plays in raising awareness of the potential of biomedical innovation. #BiotechInnovation

Congratulations to BIO member @ShionogiUS on the FDA approval of XOCOVA, the first and only oral option to prevent COVID-19 following exposure. #BioInnovation